HOCHUEN Medical Recognized as National 'Specialized, Sophisticated, Distinctive, and Innovative' Little Giant with Over 250 Global Clients

Recently, Hochuen Medical Technology Co., Ltd. (hereinafter referred to as “Hochuen”) was successfully included in the 2025 national list of specialized, refined, distinctive, and innovative “Little Giant” enterprises, owing to its outstanding capabilities in the research, development, and manufacturing of microfluidic chips, consumer healthcare products, and in vitro diagnostic consumables.

This national-level honor not only affirms Hochuen’s robust capabilities in advanced medical manufacturing technologies, but also marks its achievement of the core criteria for state-recognized “Little Giant” enterprises in terms of independent innovation, transformation of scientific and technological achievements, market share, and technological advancement.

Hochuen Medical Shenzhen Headquarters

Detection chips based on microfluidic chip technology represent the most promising product form for realizing point-of-care testing and at-home self-testing. This technology integrates multidisciplinary knowledge from materials science, biochemistry, fluid dynamics, optics, and electronics. Its manufacturing process is built upon precision machining, placing it within the realm of advanced medical manufacturing characterized by high technical barriers.

However, as an emerging technology, large-scale production remains the core bottleneck facing its current industrial chain.

Since its establishment in 2016, Hochuen has remained focused on the niche sector of microfluidic chips and medical device consumables. After nearly a decade of dedicated development, the company has established a comprehensive product portfolio supported by end-to-end core manufacturing processes and covering multiple application scenarios, successfully overcoming the industrial bottlenecks associated with large-scale production.

The company is not only capable of mass-producing micron-level chips but has also mastered a full spectrum of core processes, including high-precision mold manufacturing, multi-type precision injection molding (single-color, two-shot hard-to-hard, and hard-to-soft), liquid silicone rubber (LSR) injection molding, as well as precision die-cutting, laser cutting, molecular bonding, UV curing, and reagent kit assembly.

Leveraging its robust technical capabilities, Hochuen has built a product portfolio covering multiple scenarios, including microfluidic biochips, disposable consumables for in vitro diagnostics (IVD), point-of-care testing (POCT) kits, home-use molecular diagnostic test kits, life science research consumables, gene sequencing chips, organ-on-a-chip systems, pet disease diagnostic chips, food safety detection chips, and precision surgical instrument consumables.

In terms of quality management, Hochuen has obtained ISO 13485 certification for medical device quality management systems, AEO Advanced Customs Certification, and U.S. FDA supplier registration, ensuring that its entire process complies with professional standards in the medical device industry.

Class 100,000 Cleanroom Workshop

Building on this foundation, the company has continuously advanced its lean manufacturing reforms by introducing advanced equipment such as automatic dispensing machines, vision inspection systems, fully automatic pick-and-place machines, and semi-automatic reagent filling systems, thereby achieving visualized control over production processes. This transformation has not only significantly boosted production efficiency but also maintained product consistency errors at an industry-leading level, ensuring reliable service to global customers.

Hochuen Innovatively Launches"One-Stop Microfluidics Intelligent Manufacturing Platform"This model integrates core processes including mold design and machining, precision injection molding, die bonding, and reagent preparation, offering end-to-end services from prototype development to large-scale manufacturing. It also supports customized requirements such as assembly, quality control, packaging, and sterilization, helping customers significantly shorten their product time-to-market.

One-Stop Microfluidic Intelligent Manufacturing Platform

To support the implementation of this model, Hochuen Medical, in accordance with its global business strategic development layout and production capacity requirements, has alreadyShenzhen, Dongguan, and MalaysiaThree R&D and production bases have been established, with a total construction area exceeding 40,000 square meters. Equipped with Class 10,000 and Class 100,000 cleanrooms as well as GMP-compliant workshops, these facilities meet the production requirements for various product categories. Meanwhile,Los Angeles, USA; SingaporeEstablishing overseas sales centers enables rapid response to the technical and service needs of global customers, building a“R&D and Manufacturing + Global Services”the complete layout.

Dongguan Production Base (Left) and Malaysia Production Base (Right)

To date, Hochuen has served over 250 clients worldwide, establishing itself as a key service provider in the global microfluidics industry chain. Moving forward, Hochuen will continue to uphold its service philosophy of “customer first, quality priority, people-oriented, and pursuit of excellence,” striving to deliver more comprehensive one-stop microfluidics solutions to domestic and international clients with superior quality and higher efficiency.

As a global leading provider of medical consumable solutions, Hochuen also boasts an international first-class team dedicated to the R&D, production, and management of microfluidic chips and medical consumables.

Dr. Liu Hui, Co-Founder and Chairman of the BoardHe has previously held positions at Motorola, CombiMatrix, GenMark (Roche), and Beckman Coulter (Danaher). With over 25 years of experience in R&D, manufacturing, and management, he specializes in microfluidics, molecular diagnostics, immunoassays, hematology analyzers, and urinalysis instruments. His research findings have been published in top-tier international academic journals such as Nature and PNAS.Co-founder and General Manager, Zeng LijiangPossesses nearly 20 years of OEM production and management experience for electronic products from renowned companies such as Apple, Google, and Samsung.

In addition, Hochuen also possesses aProfessor David Beebe of the University of Wisconsin, Professor Abe Lee of the University of California, and Researcher Lin Bingcheng of the Chinese Academy of Sciencesa Scientific Advisory Committee composed of top domestic and international authorities in microfluidics.

Relying on its core team, Hochuen has achieved breakthroughs in multiple key technologies in the field of microfluidic chip research and development and production, with independently developedUltra-precision laser cutting, high-precision die cutting, chip bonding...and other technologies, successfully breaking through foreign process barriers in niche application areas and advancing microfluidics technologyFrom Laboratory Research to Industrial Commercialization。

Technical advantages continue to be translated into market competitiveness. Hochuen’s medical business has maintained rapid growth for many consecutive years, with market coverage spanning major regions including North America, Europe, and Asia. The company has established long-term, stable cooperative relationships with numerous Fortune 500 companies as well as domestic and international listed companies, becomingA Benchmark Enterprise for Technological Innovation and Industrial Application in the Field of Microfluidics.

Hochuen CMEF Booth

From “specialized” focus on niche sectors, to “refined” quality control, to “distinctive” service models and “innovative” technological breakthroughs, Hochuen vividly embodies the core values of a national-level “Little Giant” enterprise specializing in specialization, refinement, distinction, and innovation.

Looking ahead, Hochuen will continue to focus on and deepen its expertise in this field. By increasing R&D investment and strengthening its talent team, the company is committed to building a core intelligent manufacturing hub for global medical enterprises. With the vision of “safeguarding life and health with micron-level precision,” Hochuen aims to bring precision medicine into every household.